Abstract: The present invention relates to a method of preparing a polyester comprising polymerizing at least one .beta.-substituted-.beta.-propiolactone in the presence of an initiating amount of alkylzinc alkoxide in bulk or in solvent for a reaction time and temperature sufficient to produce said polyester.

Abstract: A process for producing siloxane modified polyolefin copolymers and products comprising the copolymer with the following general formula: ##STR1## wherein: x=1 to 1000; m=2 to 100; n=0 to 1000; y=1 to 3, z=0 to 2, wherein (y+z)=3; and p=1 to 200; wherein each R and R.sub.1 are independently selected from the group consisting of hydrogen, alkyl groups having 1 to 6 carbons, phenyl, benzyl and alkylphenyl having from 6 to 12 carbons; R.sub.2 is selected from the group consisting of C.sub.1 to C.sub.6 alkyl, phenyl, benzyl and alkylphenyl having from 6 to 12 carbons; R.sub.3 is selected from the group consisting of hydrogen, methyl, ethyl and propyl; and Z is selected from the group consisting of O, S, NH and NR' wherein R' is selected from the group consisting of phenyl, C.sub.1 to C.sub.4 alkyl and C.sub.1 to C.sub.3 alkylphenyl.

Abstract: The present invention relates to a novel cell line isolated from a rat osteosarcoma wherein the cell line has the following characteristics: a) a mutated p53 system, b) a normal RB-1 gene as compared to a non-tumorigenic Sprague-Dawley rat cell control, c) a normal c-myc gene as compared to a non-tumorigenic Sprague-Dawley rat cell control, d) a normal c-fos gene as compared to a non-tumorigenic Sprague-Dawley rat cell control, e) a deregulated immediate early gene response, f) a canalicular network MATRIGEL.TM.

Abstract: The present invention relates to a novel cell line isolated from a rat osteosarcoma wherein the cell line has the following characteristics: a) a mutated p53 gene incapable of expressing p53 protein, b) a normal RB-1 gene, c) a 10-fold amplified c-myc gene, d) a normal c-fos gene, e) a deregulated immediate early gene response, f) a canalicular network MATRIGEL.TM. growth pattern, g) tumorigenic in congenitally athymic mice, h) no alkaline phosphatase activity, i) an ability to produce one or more growth factors selected from the group consisting of: 1) an osteoblastic differentiation growth factor, 2) a non-heparin binding mitogenic growth factor, 3) a first heparin binding mitogenic growth factor, 4) a second heparin binding mitogenic growth factor, and 5) a third heparin binding mitogenic growth factor, and j) an ability to be serially propagated greater than sixty population doublings.

Abstract: The present invention relates to biodegradable PHA copolymers comprising at least two randomly repeating monomer units. The present invention further relates to a plastic article comprising a biodegradable copolymer, wherein the biodegradable copolymer comprises at least two randomly repeating monomer units (RRMU) wherein the first RRMU has the structure ##STR1## wherein R.sup.1 is H, or C.sub.1 or C.sub.2 alkyl, and n is 1 or 2; the second RRMU has the structure ##STR2## wherein R.sup.2 is a C.sub.4 -C.sub.19 alkyl or alkenyl; and wherein at least 50% of the RRMUs have the structure of the first RRMU. The present invention further relates to an absorbent article comprising a liquid pervious topsheet, a liquid impervious backsheet comprising a film comprising a PHA of the present invention and an absorbent core positioned between the topsheet and the backsheet.